Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Cancer Causes Control. 2009 Mar 12;20(7):1039. doi: 10.1007/s10552-009-9321-3

Table 1. Characteristics of study population: Group Health, Seattle, WA – Years of recruitment 2004 - 2005 (N = 192*).

Age, y (mean, SD) 42.4 (1.4)
Age at menarche, y (mean, SD) 12.8 (1.3)
Age at first birth§, y (mean, SD) 29.0 (5.8)
BMI, kg/m2 (mean, SD) 25.7 (4.6)
Height, m (mean, SD) 1.65 (0.07)
Weight, kg (mean, SD) 70.1 (13.4)
Waist:Hip ratio (mean, SD) 0.79 (0.06)
Parity (n, %)
Nulliparous 55 (28.6)
Had 1 or 2 children 69 (35.9)
Had 3+ children 65 (33.8)
Had a history of breast-feeding§ (n, %) 111 (82.2)
Had a history of hormone useŦ (n, %) 137 (71.4)
First degree relative with breast and/or ovarian cancer (n, %) 24 (12.5)
Smoking status (n, %)
Current 8 (4.2)
Former 54 (28.1)
Never 128 (66.7)
Race / ethnicity (n, %)
Asian 14 (7.3)
White 166 (86.5)
Other 10 (5.2)
Years of school completed (n, %)
≤ 12 12 (6.2)
13 – 15 49 (25.5)
16 57 (29.7)
≥ 17 years 72 (37.5)
Income (n, %)
≤ $49,999 29 (15.1)
$50,000 - $75,000 44 (22.9)
> $75,000 90 (46.9)
Prefer not to answer 26 (13.5)
§

Among parous women only (n = 135)

*

Numbers may not add up to 192 for some characteristics due to missing values

Ŧ

Use of oral contraceptives, hormone patches, hormone injections, hormone implants, or intrauterine devices containing progesterone at any time prior to the 6 month-period before the screening mammogram